You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,273,448


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,273,448
Title:Medium containing uridine and N-acetyl-D-mannosamine
Abstract: Provided are a novel medium for expressing glycoproteins by culturing cells and a method for producing glycoproteins by culturing cells in the medium. Further provided are a medium comprising uridine and N-acetyl-D-mannosamine for the use of expression of a glycoprotein by culturing cells and a method for producing glycoproteins by culturing cells in the medium.
Inventor(s): Matev; Miroslav (Kobe, JP), Takahashi; Kenichi (Kobe, JP), Kakimoto; Shinji (Kobe, JP), Kotani; Ayaka (Kobe, JP)
Assignee: JCR PHARMACEUTICALS CO., LTD. (Ashiya-shi, JP)
Application Number:15/365,331
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,273,448

Understanding the Patent Document

To analyze the claims and patent landscape of United States Patent 10,273,448, it is crucial to start by understanding the structure and content of the patent document itself.

Front Page and Bibliographic Data

The front page of a U.S. patent contains essential bibliographic data identified by INID codes. These codes include the document number, document type, application number, date of application, date of patent, IPC classification, national classification, title of the invention, references, abstract, and field of search[1].

Drawings and Specification

The drawings section illustrates the technical details of the invention, following strict drafting guidelines set by the patent office. The specification is a written description of the invention, including discussions of prior art, descriptions of the drawings, and how the invention solves a specific technical problem[1].

Claims

The claims section defines the scope of protection of the patent. These claims must be novel, non-obvious, and useful. The first claim sets the foundation for the legal boundaries of the invention, similar to how a property deed defines physical boundaries[1].

Patent 10,273,448: A Detailed Look

Title and Abstract

The title of the patent provides a concise description of the invention, limited to 500 characters or less. The abstract offers a brief, non-technical description of the invention, giving an overview of its purpose and functionality[1].

Claims Analysis

Each claim in the patent defines a specific aspect of the invention. For example, if the patent is for a technological device, the claims might include details about its components, their interactions, and the functions they perform. Here, it is important to identify the independent and dependent claims, as they outline the core and additional features of the invention.

Prior Art and Novelty

The patent examiner reviews prior art to determine if the claimed invention is novel and non-obvious. If the claimed invention is anticipated by prior art, the claims may be rejected under 35 U.S.C. ยง 102(a)(1) and (2)[3].

Patent Landscape Analysis

Competitive Intelligence

Analyzing the patent landscape involves reviewing file wrappers, which contain detailed interactions between the patent applicant and the patent examiner. This includes arguments over patentability, prior art references, and any adjustments to the claims. This information is crucial for understanding the competitive landscape and making informed investment decisions[3].

Inter Partes Review (IPR) and Post-Grant Review (PGR)

The Leahy-Smith America Invents Act (AIA) introduced IPR and PGR, allowing anyone to challenge patents before the USPTO. This process is often faster and less expensive than judicial proceedings and can significantly impact the validity of patent claims. Understanding how these processes work is vital for assessing the strength and potential challenges to the patent[2].

Patentable Subject Matter

The Supreme Court's Alice test (Alice/Mayo framework) is a two-step test to determine if patent claims are directed to ineligible subject matter, such as laws of nature, natural phenomena, or abstract ideas. If the claims do not pass this test, they must contain an "inventive concept" to be patentable[2].

Technical and Legal Context

Technical Details

The specification and drawings of the patent provide detailed technical information about the invention. This includes how the invention works, its components, and how it solves a specific technical problem. For example, in a patent for a portable electronic device, the technical details might include descriptions of the housing, antenna, and frequency shields[1].

Legal Status and Ownership

The patent document also includes information about the applicant, inventors, assignee, and patent attorney or firm. The assignee is the owner of the patent at the time it was issued, which can be a person, company, or organization. Understanding the legal status and ownership can be crucial for licensing, litigation, and other legal considerations[1].

Trends and Statistics

Patent Litigation and NPE Filings

Recent trends show an increase in patent litigation and filings by non-practicing entities (NPEs). This can impact the patent landscape significantly, as NPEs often challenge patent validity through IPR and PGR processes. In Q3 2024, for instance, US patent litigation increased by 20% compared to Q3 2023, with NPE filings on the rise[5].

Sector-Specific Patent Analysis

Sector-specific analyses, such as those conducted by the Department of Energy for hydrogen and fuel cell technologies, provide insights into patent trends and distributions. For example, in 2021, there were 298 patents associated with 80 technologies in this sector, indicating active innovation and competition[4].

Competitive Analysis and Strategic Insights

File Wrapper Analysis

Analyzing the file wrapper of a patent provides deep insights into the prosecution history, including arguments between the applicant and the examiner, prior art references, and any adjustments to the claims. This information can be used to understand the strengths and weaknesses of the patent and to identify potential areas for challenge or improvement[3].

Patent Landscape Mapping

Mapping the patent landscape involves identifying related patents, understanding the distribution of patents among different organizations (e.g., private companies, national laboratories, universities), and analyzing trends over time. This helps in identifying key players, technological gaps, and potential areas for innovation[4].

Key Takeaways

  • Patent Structure: Understanding the front page, drawings, specification, and claims of a patent is essential for analyzing its content and scope.
  • Novelty and Non-Obviousness: Claims must overcome prior art to be considered novel and non-obvious.
  • Legal Challenges: IPR and PGR processes can significantly impact patent validity and should be considered in the patent landscape analysis.
  • Technical Details: The specification and drawings provide critical technical information about the invention.
  • Trends and Statistics: Keeping abreast of patent litigation trends and sector-specific analyses can provide strategic insights.
  • Competitive Analysis: File wrapper analysis and patent landscape mapping are crucial for competitive intelligence.

FAQs

Q: What is the purpose of the INID codes on the front page of a U.S. patent?

A: INID codes identify various bibliographic data on the front page of a U.S. patent, such as the document number, application number, and classification codes.

Q: How do IPR and PGR processes impact patent validity?

A: IPR and PGR processes allow anyone to challenge patents before the USPTO, potentially leading to the cancellation of patent claims if they are found to be invalid.

Q: What is the significance of the Alice test in patent law?

A: The Alice test is a two-step framework used to determine if patent claims are directed to ineligible subject matter and whether they contain an "inventive concept" to be patentable.

Q: Why is analyzing the file wrapper important?

A: Analyzing the file wrapper provides insights into the prosecution history, including arguments over patentability, prior art references, and claim adjustments, which can be crucial for understanding the patent's strengths and weaknesses.

Q: How can sector-specific patent analyses help in strategic decision-making?

A: Sector-specific analyses provide insights into patent trends, distributions, and technological gaps, helping identify key players and potential areas for innovation and investment.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. CRSreports.congress.gov: The Patent Trial and Appeal Board and Inter Partes Review.
  3. IPCheckups.com: Patent file wrappers as a tool for competitive intelligence.
  4. Energy.gov: hfto-2021-patent-analysis.pdf - Department of Energy.
  5. RPXcorp.com: Q3 in Review: US NPE Upswing Continues as UPC Comes Further into Focus.

More… ↓

⤷  Subscribe

Details for Patent 10,273,448

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Biomarin Pharmaceutical Inc. NAGLAZYME galsulfase Injection 125117 May 31, 2005 ⤷  Subscribe 2034-05-31
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.